2Mon·

Newron Pharmaceuticals

Sam M. · 2025-10-02T11:55:42.638410Z

At last it's picking up $NWRN let's see where it goes!

At last it's picking up $NWRN (+5.13%) let's see where it goes!

34Positions

€137,184.88

32.34%

7 Comments

Anderlé MPoint@Anderle

2Mon

Looks quite reasonable $NWRN:

+ EV / Sales (5.29)
+ Gross Margin TTM (98.26%)
+ Rule-of-40 Score TTM (432.88%)
+ Sales Growth TTM (467.18%)
+ PEG TTM (0.04)
+ Return on equity LJ (1086.63%)
+ EBIT margin LJ (50.93%)

- Debt ratio (34.68)
- Equity ratio LJ (2.28%) ✌🏻

•

PiHu@PiHu

2Mon

@Anderle huhu, where did you get the data so quickly? :)

•

Anderlé MPoint@Anderle

2Mon

@PiHu I'm registered at https://aktien.guide/ (premium account) I think the site is really great and very clear ✌🏻

•

Sam M.@Sam_Mumm

2Mon

@Anderle There is always the risk that Evenamide will not be approved and then the price will plummet.

•

Anderlé MPoint@Anderle

2Mon

@Sam_Mumm Correct, the risk exists for all pharmaceutical and biotechnology companies.

•

PiHu@PiHu

2Mon

Congratulations, what do they do and how did you find them? 🎈

••

Sam M.@Sam_Mumm

2Mon

@PiHu A small pharmaceutical company from northern Italy. Working on approval for Evenamide, a drug for schizophrenia. But with these small pharmaceutical companies there is always a VERY high risk that the approval will fail. I hope for a takeover beforehand. I work in this field.

•